Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10000745 Therapeutic nuclease compositions and methods

Patent 10000745 was granted and assigned to University of Washington on June, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

University of Washington

0

Current Assignee

University of Washington

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Martha Hayden-Ledbetter0

Jeffrey A. Ledbetter0

Keith Elkon0

Xizhang Sun0

Date of Patent

June 19, 2018

0

Patent Application Number

145995670

Date Filed

January 19, 2015

0

Patent Citations Received

US Patent 12129288 Polynucleotides heterodimers of soluble interferon receptors and uses thereof

0

US Patent 10988745 Therapeutic nuclease-albumin fusions and methods

US Patent 11034944 Therapeutic nuclease compositions and methods

US Patent 11306297 Therapeutic nuclease compositions and methods

US Patent 12077790 Optimized binuclease fusions and methods

0

Patent Primary Examiner

0

Patent abstract

Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10000745 Therapeutic nuclease compositions and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool